Articles
Time to take conflict of interest seriously

Time to take conflict of interest seriously

Chris Stevenson suggests that conflict of interest is becoming more common across the industry, and questions whether not only medical professionals should seriously consider it. There are few phrases in our industry that create such a closed mind as ‘Conflict of Interest’. Ask many people involved in working with…

Articles
What Are IDEAs Made Of: Scenario planning

What Are IDEAs Made Of: Scenario planning

This week sees Mike Rea being rather verbose about scenario planning in pharma, it must be all the different options he is weighing up! Cards on the table: no two ‘scenario planning’ projects are the same, or should be the same. They have different goals, different inputs...

Articles
The strength of online patient communities

The strength of online patient communities

As pharmaphorum continues to interview key people changing the world of pharma, we caught up with Jeanne Barnett to hear more about CysticFibrosis.com. It seems that an ever increasing volume of clinical study work is being conducted outside the mature global pharma markets...

Sales & Marketing

Sales & Marketing
Solution Spotlight: BrandPRO Biopharma
Sponsored

Solution Spotlight: BrandPRO Biopharma

Strong strategy on paper can unravel when priorities collide. BrandPRO Biopharma gives pharmaceutical teams a place to put their decisions to the test

Digital

Market Access

Editor's Picks

  1. UK budget includes £1bn biopharma investment package
  2. HHS doubles down on controversial peptides plan
  3. Lilly's triple G overpowers Ozempic in diabetes trial
  4. UK puts £100m into "world-first" AI biosecurity facility
  5. US gives $99m for Ebola jab project, as cases spread in Africa

Newsletters and Deep Dive
digital magazine

Oncology

more

Patients

more

R&D

more